Ablation of supraventricular tachycardia in elderly persons presents a challenging problem to electrophysiologists. Friable cardiac structures, prone to catheter perforation, comorbid ...

Medtronic (NYSE: MDT) announced today that the FDA approved an early feasibility study to evaluate its Affera system for ...

TULSA is a targeted prostate cancer treatment that uses ultrasound to destroy tumors while preserving healthy tissue.

Ablation of cardiac arrhythmias in children under 18 years of age without the use of fluoroscopy is an effective procedure, ...

The FDA approved an early feasibility study of Medtronic’s Affera mapping and ablation system and Sphere-9 catheter in ...

A multicenter study has described and validated a new strategy for guiding ablation procedures in patients with complex ...

A multicenter study led by Hospital Clínico San Carlos and the CNIC has validated a new preoperative planning method using ...

Abbott has received an FDA clearance for the latest version of its sensor-laden catheter used to map out the electrical ...

Welcome to Abbott's third quarter 2024 earnings conference call. [Operator instructions] This call is being recorded by ...

Abbott (NYSE: ABT) today announced new milstones supporting its suite of pulsed field ablation (PFA) solutions in ...

Ablation therapy consists of a minimally invasive treatment, which can be used for treating cancer by destroying tumors and other abnormal tissues within the body. It uses either extremely high or ...